Safety, Tolerability, and Immunogenicity of VAL-506440 in Healthy Adult Subjects

A Study to Evaluate the Efficacy and Safety of ZX-7101A Tablets in Adults with Uncomplicated Influenza

NCT05702489 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Participants From Birth to < 1 Year With Influenza-Like Symptoms

NCT03653364 ·Status: COMPLETED ·Phase: PHASE3

Study of GP681 Tablets Compared With Placebo in Patients With Influenza at High Risk of Influenza Complications

NCT06573008 ·Status: RECRUITING ·Phase: PHASE3

Safety, Tolerability, and Pharmacokinetics of SAB-176 in Healthy Participants

NCT04471038 ·Status: COMPLETED ·Phase: PHASE1

Study of S-033188 (Baloxavir Marboxil) Compared With Placebo or Oseltamivir in Patients With Influenza at High Risk of Influenza Complications

NCT02949011 ·Status: COMPLETED ·Phase: PHASE3

Evaluation the Safety and Tolerance of GP681 Tablets in Healthy Subjects

NCT04729764 ·Status: COMPLETED ·Phase: PHASE1

Duvelisib Ameliorates Manifestations of Pneumonia in Established Novel Coronavirus Infection (COVID-19)

NCT04487886 ·Status: COMPLETED ·Phase: PHASE2

A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia

NCT04363736 ·Status: COMPLETED ·Phase: PHASE2

Evaluating the Use of Oseltamivir for the Treatment of Influenza in Adults

NCT01314911 ·Status: COMPLETED ·Phase: NA

Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Participants With Influenza-Like Symptoms

NCT03629184 ·Status: COMPLETED ·Phase: PHASE3

Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults

NCT02008344 ·Status: COMPLETED ·Phase: PHASE3

Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Chinese Pediatric Participants 1 to <12 Years of Age With Influenza Symptoms

NCT06774859 ·Status: COMPLETED ·Phase: PHASE3

Baloxavir Versus Oseltamivir for Nursing Home Influenza Outbreaks

NCT05012189 ·Status: UNKNOWN ·Phase: PHASE4

A Phase II, Multicenter, Randomized, Placebo -Controlled, Study To Evaluate The Efficacy and Safety Of Intramuscular Peramivir 600 mg In Subjects With Uncomplicated Acute Influenza

NCT00705406 ·Status: COMPLETED ·Phase: PHASE2

A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household Contacts

NCT06094010 ·Status: RECRUITING ·Phase: PHASE3

First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19.

NCT04535167 ·Status: COMPLETED ·Phase: PHASE1

Efficacy of Tocilizumab on Patients With COVID-19

NCT04356937 ·Status: COMPLETED ·Phase: PHASE3

Dose Range Study to Evaluate the Efficacy and Safety of AV5080 in Patients With Influenza

NCT05095545 ·Status: COMPLETED ·Phase: PHASE2

Clinical Trial of Efficacy and Safety of ММН-407 in the Treatment of Influenza in Outpatient Adults

NCT04250311 ·Status: SUSPENDED ·Phase: PHASE3

Clinical Trial to Evaluate the Safety of RQ-01 in SARS-CoV-2 Positive Subjects

NCT06063330 ·Status: COMPLETED ·Phase: PHASE1

Treatment of Severe Influenza A Infection

NCT02108366 ·Status: COMPLETED ·Phase: PHASE3

Oseltamivir and Baloxavir Marboxil for Prophylaxis Against Influenza Under a Hospital-based Setting

NCT06762587 ·Status: NOT_YET_RECRUITING ·Phase: NA

Safety, Tolerability and Clinical Effect of Danirixin in Adults With Influenza

NCT02469298 ·Status: COMPLETED ·Phase: PHASE2

A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled MBS-COV (SNS812) in Healthy Participants

NCT05677893 ·Status: COMPLETED ·Phase: PHASE1

First-in-Human Study to Investigate the Safety and Tolerability and Pharmacokinetics of HS-10383

NCT05429723 ·Status: UNKNOWN ·Phase: PHASE1